COM:CEREVEL

Cerevel Therapeutics

Stock

Last Close

44.63

31/07 20:00

Market Cap

7.46B

Beta: -

Volume Today

15.03M

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Aug '14	Aug '15	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	2.40M -	2.72M 13.14%
cost of revenue	3.02M -	5.27M 74.35%					5.63M -
gross profit	-617K -	-2.55M 312.80%					-5.63M -
selling and marketing expenses							-5.63M -
general and administrative expenses	14.48M -	15.95M 10.09%	33.17M 108.01%	45.81M 38.12%	58.24M 27.13%	87.59M 50.39%	112.62M 28.58%
selling general and administrative expenses	14.48M -	15.95M 10.09%	33.17M 108.01%	45.81M 38.12%	58.24M 27.13%	87.59M 50.39%	107.00M 22.16%
research and development expenses	14.16M -	9.68M 31.59%	50.29M 419.35%	103.30M 105.40%	161.85M 56.68%	280.26M 73.15%	334.64M 19.40%
other expenses	3.02M -	5.27M 74.35%	9K 99.83%	-3.27M 36,477.78%	-5.39M 64.72%	6.88M 227.54%
cost and expenses	34.68M -	36.16M 4.27%	83.46M 130.79%	149.12M 78.66%	220.10M 47.60%	367.85M 67.13%	447.26M 21.59%
operating expenses	31.66M -	30.90M 2.41%	83.46M 170.13%	149.12M 78.66%	220.10M 47.60%	367.85M 67.13%	441.64M 20.06%
interest expense	68K -	30K 55.88%				9.62M -	10.57M 9.86%
ebitda	-27.74M -	-27.47M 0.96%	-36.84M 34.12%	-149.12M 304.72%	-220.10M 47.60%	-367.85M 67.13%	-441.64M 20.06%
operating income	-29.26M -	-28.18M 3.69%	-83.46M 196.21%	-149.12M 78.66%	-220.10M 47.60%	-367.85M 67.13%	-447.26M 21.59%
depreciation and amortization	1.52M -	657K 56.69%	46.62M 6,995.74%	397K 99.15%	2.73M 587.91%	4.90M 79.53%	5.63M 14.77%
total other income expenses net	-63K -	22K 134.92%	-44.88M 204,104.55%	-3.05M 93.20%	-5.24M 71.67%	16.50M 415.07%	14.93M 9.52%
income before tax	-29.32M -	-28.16M 3.97%	-128.34M 355.85%	-152.17M 18.56%	-225.33M 48.08%	-351.35M 55.92%	-432.34M 23.05%
income tax expense	-1K -	-1K 0%	45K 4,600%	-24K 153.33%	-2.89M 11,933.33%	160K 105.54%	503K 214.37%
net income	-29.32M -	-28.16M 3.97%	-128.39M 355.99%	-152.14M 18.50%	-222.45M 46.21%	-351.51M 58.02%	-432.84M 23.14%
weighted average shs out	14.24M -	14.24M 0%	127.12M 792.81%	73.64M 42.07%	136.58M 85.46%	151.27M 10.76%	162.06M 7.13%
weighted average shs out dil	36.21M -	6.17M 82.97%	127.12M 1,961.69%	73.64M 42.07%	136.58M 85.46%	151.27M 10.76%	162.06M 7.13%
eps	-2.06 -	-1.98 3.88%	-1.01 48.99%	-2.07 104.95%	-1.63 21.26%	-2.32 42.33%	-2.67 15.09%
epsdiluted	-0.81 -	-4.57 464.20%	-1.01 77.90%	-2.07 104.95%	-1.63 21.26%	-2.32 42.33%	-2.67 15.09%

All numbers in (except ratios and percentages)